2025 Regular Session • Missouri Legislature
HB1118
Legislative Summary
Creates provisions relating to abuse-deterrent opioid analgesic drug products
Demographic Impact
Overall analysis of equity impact
75% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/29/2025
Introduced and Read First Time (H)
House of Representatives
1/30/2025
Read Second Time (H)
House of Representatives
2/6/2025
Referred: Insurance(H)
House of Representatives
2/24/2025
Public Hearing Scheduled, Bill not Heard (H)
House of Representatives
Status Information
Current Status
Introduced(1/29/2025)
Chamber
House of Representatives
Committee
Insurance(House of Representatives)
Sponsors
Republican: 1
Primary Sponsor
Chris Brown
Republican